Doherty, Anne’s team published research in Clinics in perinatology in 2020-05-20 | CAS: 21829-25-4

Clinics in perinatology published new progress about Endothelial inflammation; Fetal growth restriction; Hemodynamic adaptation; Preeclampsia; Vascular remodeling. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Formula: C17H18N2O6.

Doherty, Anne published the artcileHemodynamic Complications in Pregnancy: Preeclampsia and Beyond., Formula: C17H18N2O6, the main research area is Endothelial inflammation; Fetal growth restriction; Hemodynamic adaptation; Preeclampsia; Vascular remodeling.

Normal pregnancy is a complex and dynamic process that requires significant adaptation from the maternal system. Failure of this adaptive process in pregnancy contributes to many pregnancy related disorders, including the hypertensive disorders of pregnancy. This article discusses placental development and how abnormalities in the process of vascular remodeling contribute to the multisystem maternal and fetal disease that is preeclampsia and fetal growth restriction. We review some of the consequences of this condition on the mother and fetus, aspects of the clinical management of preeclampsia and how it can influence both mother and infant in the postnatal period and beyond.

Clinics in perinatology published new progress about Endothelial inflammation; Fetal growth restriction; Hemodynamic adaptation; Preeclampsia; Vascular remodeling. 21829-25-4 belongs to class pyridine-derivatives, name is Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, and the molecular formula is C17H18N2O6, Formula: C17H18N2O6.

Referemce:
Pyridine – Wikipedia,
Pyridine | C5H5N – PubChem